Cytokinetics, Incorporated (CYTK)

NasdaqGS • Currently down 0.37 (-0.55%) in today's trading session

Track congressional stock trades in Cytokinetics, Incorporated (CYTK). Analyze trading activity from Nancy Pelosi and other members of Congress with real-time financial disclosure data, interactive price charts, and detailed transaction records.

Cytokinetics, Incorporated is currently trading at $66.35, positioned at 89% of its 52-week range ($29.31 – $70.98). View which politicians have recently bought or sold CYTK and how their trades align with market movements.

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only

Copy Portfolio Claim Free Asset

Live portfolio tracking

Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price

$66.35

24h Change

-0.37 (-0.55%)

52 Week Range

$29.31—$70.98

View on NASDAQ

Cytokinetics, Incorporated Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for CYTK

Select to highlight on chart

Politician

0 transactions

Include Non-Compliant

Compliance: 0%


No data

Select transactions to view their annotations on the chart

Earnings

Next Report

Q1 2026

5 May

EPS Est.

$-1.64

Rev. Est.

$8.6M

Days Until

Recent Quarters

Q4 202524 Feb

EPS$-1.50

Miss 1.4%

Q3 20255 Nov

EPS$-1.54

Beat 3.1%

Q2 20257 Aug

EPS$-1.12

Beat 16.4%

Q1 20256 May

EPS$-1.36

Beat 3.5%

Q4 202427 Feb

EPS$-1.26

Beat 2.3%

Q3 20246 Nov

EPS$-1.36

Miss 7.1%

Q2 20248 Aug

EPS$-1.31

Miss 28.4%

Q1 20248 May

EPS$-1.33

Miss 14.7%

Q4 202327 Feb

EPS$-1.38

Miss 34.0%

Q3 20232 Nov

EPS$-1.35

Miss 87.5%

Q2 20233 Aug

EPS$-1.34

Miss 8.9%

Q1 20234 May

EPS$-1.38

Miss 11.3%

Q4 20221 Mar

EPS$-1.45

Miss 18.9%

Q3 20223 Nov

EPS$-1.28

Miss 7.6%

Q2 20224 Aug

EPS$-0.23

Beat 77.9%

Q1 20224 May

EPS$-1.02

Miss 9.7%

Q4 202124 Feb

EPS$-0.36

Beat 59.5%

Q3 20213 Nov

EPS$-0.95

Miss 26.7%

Q2 20215 Aug

EPS$-0.86

Miss 32.3%

Q1 20216 May

EPS$-0.66

Miss 11.9%

Q4 202025 Feb

EPS$-0.62

Miss 29.2%

Q3 20204 Nov

EPS$-0.05

Beat 91.5%

Q2 20206 Aug

EPS$-0.68

Miss 19.3%

Q1 20206 May

EPS$-0.66

Miss 32.0%

Q4 20193 Mar

EPS$-0.52

Miss 23.8%

Q3 201931 Oct

EPS$-0.50

Beat 10.7%

Q2 20198 Aug

EPS$-0.56

Miss 5.7%

Q1 20199 May

EPS$-0.54

Miss 14.9%

Q4 201821 Feb

EPS$-0.48

Beat 12.7%

Q3 20181 Nov

EPS$-0.40

Beat 24.5%

Q2 201826 Jul

EPS$-0.51

Miss 4.1%

Q1 201826 Apr

EPS$-0.56

Miss 5.7%

Q4 201715 Feb

EPS$-0.75

Miss 5.6%

Q3 201726 Oct

EPS$-0.60

Beat 6.3%

Q2 20172 Aug

EPS$-0.60

Beat 9.1%

Q1 201727 Apr

EPS$-0.62

Miss 463.6%

Q4 201616 Feb

EPS$0.16

Beat 161.5%

Q3 201627 Oct

EPS$0.74

Beat 355.2%

Q2 201628 Jul

EPS$-0.29

Miss 3.6%

Q1 201628 Apr

EPS$-0.31

Beat 16.2%

Q4 201516 Feb

EPS$-0.24

Beat 25.0%

Q3 201529 Oct

EPS$-0.23

Beat 20.7%

Q2 201529 Jul

EPS$-0.27

Beat 3.6%

Q1 201530 Apr

EPS$-0.23

Miss 187.5%

Q4 201412 Feb

EPS$0.23

Beat 235.3%

Q3 201430 Oct

EPS$-0.16

Beat 40.7%

Q2 201430 Jul

EPS$-0.23

Beat 37.8%

Q1 20146 May

EPS$-0.27

Beat 25.0%

Q4 20136 Feb

EPS$0.21

Beat 362.5%

Q3 201330 Oct

EPS$-0.43

Miss 377.8%

Q2 201331 Jul

EPS$-0.58

Miss 5.5%

Q1 201330 Apr

EPS$-0.54

Beat 0.0%

Q4 20125 Feb

EPS$-0.42

Beat 30.0%

Q3 201230 Oct

EPS$-0.42

Beat 30.0%

Q2 201231 Jul

EPS$-0.78

Miss 2.6%

Q1 201226 Apr

EPS$-0.78

Beat 9.3%

Q4 20112 Feb

EPS$-0.96

Beat 9.4%

Q3 201127 Oct

EPS$-0.90

Beat 23.1%

Q2 201128 Jul

EPS$-1.38

Miss 115.6%

Q1 201127 Apr

EPS$-1.08

Beat 5.3%

Q4 201014 Feb

EPS$-1.02

Beat 23.3%

Q3 201028 Oct

EPS$-1.14

Beat 8.8%

Q2 201028 Jul

EPS$-1.26

Miss 4.1%

Q1 201029 Apr

EPS$-1.20

Miss 0.8%

Q4 20093 Feb

EPS$-1.26

Beat 4.5%

Q3 200928 Oct

EPS$-0.84

Beat 34.9%

Q2 200929 Jul

EPS$5.94

Beat 96.7%

Q1 200930 Apr

EPS$-1.26

Miss 0.8%

Q4 200810 Feb

EPS$-1.32

Beat 43.1%

Q3 200830 Oct

EPS$-1.98

Beat 10.0%

Q2 200831 Jul

EPS$-1.86

Beat 6.5%

Q1 200829 Apr

EPS$-1.68

Beat 11.6%

Q4 200731 Jan

EPS$-1.62

Beat 33.3%

Q3 200731 Oct

EPS$-1.44

Beat 38.7%

Q2 200731 Jul

EPS$-1.62

Beat 25.4%

Q1 200726 Apr

EPS$-1.50

Beat 37.8%

Q4 200631 Jan

EPS$-2.46

Beat 29.5%

Q3 200626 Oct

EPS$-2.46

Beat 18.3%

Q2 200627 Jul

EPS$-2.22

Beat 23.2%

Q1 200627 Apr

EPS$-2.16

Beat 25.8%

Q4 200531 Jan

EPS$-2.28

Beat 19.4%

Q3 200526 Oct

EPS$-2.10

Beat 13.9%

Q2 200527 Jul

EPS$-2.22

Beat 19.0%

Q1 200527 Apr

EPS$-2.22

Beat 17.2%

Q4 20043 Feb

EPS$-2.52

Miss 6.8%

Q3 200412 Nov

EPS$-2.18

Q3 200421 Oct

EPS$-2.16

Beat 25.0%

Q1 200414 Jun

EPS$-15.39

Q3 200331 Dec

EPS$-25.65

Q2 200330 Sept

EPS$-25.65

Q1 200330 Jun

EPS$-24.66

Q4 200231 Mar

EPS$-23.06

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

No similar stocks found

No congressional trading patterns available for recommendations

Cytokinetics, Incorporated (CYTK)

Want to automatically copy Pelosi trades?

Cytokinetics, Incorporated Price History and Technical Analysis

Congressional Trading Activity for CYTK

Stock Overview

Market Data

Fundamentals

Company Information

Earnings

Next Report

Recent Quarters

Stock Splits

Split History

Similar Stocks

Cytokinetics, Incorporated (CYTK)

Want to automatically copy Pelosi trades?

Cytokinetics, Incorporated Price History and Technical Analysis

Congressional Trading Activity for CYTK

Stock Overview

Market Data

Fundamentals

Company Information

Earnings

Next Report

Recent Quarters

Stock Splits

Split History

Similar Stocks

Track CYTK in Congress